Skip to main content

Table 5 ECG interpretation at each time point in patients randomized to vasopressin or norepinephrine (N = 121)

From: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine

  Vasopressin (n= 65) Norepinephrine (n= 56) P value
Variable, n (%) Baseline ( n = 61) 6 hours ( n = 43) Day 2 ( n = 44) Day 4 ( n = 39) Baseline ( n = 54) 6 hours ( n = 40) Day 2 ( n = 48) Day 4 ( n = 35)  
Normala 19 (31) 15 (35) 14 (32) 19 (49) 10 (19) 12 (30) 14 (29) 8 (23) 0.267
Ischemiaa 9 (15) 6 (14) 8 (18) 3 (8) 9 (17) 2 (5) 3 (6) 3 (9) 0.099
Atrial fib/ flutter/PSVT 6 (10) 10 (23) 7 (16) 4 (10) 15 (28) 13 (33) 14 (29) 8 (23) 0.427
Bundle branch block 6 (10) 4 (10) 6 (14) 4 (10) 7 (13) 4 (10) 7 (15) 7 (20) 0.359
ST elevation 6 (10) 4 (10) 3 (7) 2 (5) 4 (7) 3 (8) 3 (6) 1 (3) 0.869
ST depression 5 (9) 4 (10) 6 (14) 1 (3) 8 (15) 2 (5) 2 (4) 3 (9) 0.317
T inversion 10 (16) 10 (23) 8 (18) 6 (15) 12 (22) 8 (20) 11 (23) 8 (23) 0.530
Q wave 11 (18) 3 (7) 6 (14) 7 (18) 12 (22) 8 (20) 10 (21) 9 (26) 0.039
Ventricular rhythm 0 (0) 0 (0) 0 (0) 0 (0) 1 (2) 0 (0) 1 (2) 0 (0) -b
Arrhythmiac 6 (10) 10 (23) 7 (16) 4 (10) 16 (30) 13 (33) 15 (31) 8 (23) 0.339
  1. ECG findings at each time point for patients randomized to vasopressin and norepinephrine. Values are expressed as n (%). P value is based on logistic mixed-effects model and is for the null hypothesis of no difference in ECG interpretation between the treatment groups at 6 hours, day 2, and day 4, adjusted for baseline interpretation. ECG interpretation results are based only on the data of Reader 2, blinded to randomization group and troponin level. aThe reader was asked for an overall assessment of whether the ECG was normal or abnormal, and whether, in his opinion, the ECG changes represented ischemia. bEvent rate is too low for P-value calculation. cArrhythmia includes atrial fibrillation, atrial flutter, paroxysmal supraventricular tachyarrhythmia, and ventricular rhythm.